Michael Mithoefer, MD, Clinical Assistant Professor of Psychiatry at the Medical University of South Carolina. In 2009, he has completed the first FDA approved clinical trial of MDMA-assisted psychotherapy in military veterans, firefighters and police officers with PTSD.
Speaker Disclosures:
Financial: Dr. Michael Mithoefer has employment relationships with Columbia University, Bassett Healthcare Network, University of South Carolina, Lykos Therapeutics and has ownership interest in Awakn Life Sciences. He is a sub-investigator and therapist at Zen Therapeutics and a consultant with MAPS. Dr. Mithoefer receives a speaking honorarium and recording royalties from PESI, Inc.
Non-financial: Dr. Michael Mithoefer is a fellow of the American Psychiatric Association.